Market Transformation Series: Life Sciences Meetings (Recorded May 18, 2020)
ELI member? Log in now to view this course.
Not a member? Sign up today to view this course.
See pricingIn Partnership With
Objective:
If you are a part of meetings that revolve around the health sciences, medical or life sciences fields, you know you have an uncertain future ahead. Medical meetings have mostly canceled, postponed, or have been converted into virtual meetings in 2020 due to the Coronavirus crisis. It is a tough pivot to undergo significant transformations—changing how staffers communicate, adding necessary flexibility in responding and adapting to new demands for meeting formats and styles, canceling, and rescheduling contracts,—all while navigating complex compliance laws and regulations. This webinar will focus on the effects of the Coronavirus on planning medical/life science meetings in the future and discuss how we might weather the storm.
Learning Outcomes:
- Updates on the status of medical meetings in the U.S and Europe
- Changing regulations as a result of the pandemic
- Virtual meetings and the rapid release of new technology
- Legal disclaimers and new Force Majeure language
- The new HCP experience
Christian-C. Roth
Christian-Claus Roth has been employed at Novartis Pharma since 2001, in different roles of increasing responsibility. After his studies in Business Administration he started his career with the International Pharmaceutical wholesaler GEHE Pharma Handel GmbH and later Celesio AG, in Germany.
From there he moved to the Novartis Pharma affiliate in Bern, Switzerland, where he set up the congress and event department for the Swiss market, shortly later being promoted to the Global Headquarter in Basel with responsibility for the Pain and Urology Areas as International Congress Manager, with additional responsibility later for the Bone area.
Christian now oversees the Scientific Engagement Governance focusing on the impact of external regulatory requirements on global medical event management – one of several key areas for which the team is responsible. Additionally, he regularly participates as a panel member and speaker at conferences. In July 2017 Christian was honored by ‘Successful Meetings’ as one of the most influential strategists in the meetings industry worldwide.
John P. Oroho
JOHN PATRICK OROHO, Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia.
Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance and Regulatory Counseling Department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti kickback statute, False Claim Act, and Medicare and Medicaid fraud and abuse.
Mr. Oroho previously served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.
Mr. Oroho has an extensive pharmaceutical regulatory and compliance background. He spent three years as General Counsel for the company now known as QPharma, Inc.
Mr. Oroho received a J.D. from the University of Notre Dame School of Law in 1985 and a B.S. from the United States Merchant Marine Academy, where he graduated with honors in 1978.
Michael Mahoney HMCC
View Instructor’s ProfileMichael Varlotta
Michael’s career in Bio Pharm spans for over 20 years in Bio Pharm and the last 14 in Medical education as part of medical Affairs and marketing. Currently Michael position oversees all Peer to Peer interaction. His efforts are now focused on Speaker Programs, Ad Boards and KOL engagement. He was the lead for operationalizing transparency for J&J. In this role, he harmonized policies and procedures for the pharma and device sectors of J&J. He has also developed a streamline process and state of the art system for grant, advisory boards and speaker bureaus while increasing both internal and external customer satisfaction with the process.
Prior to his role in medical education he was in brand marketing and sales as well as worked clinically as a registered vascular technologist. Michael has also presented at numerous industry meetings as an expert on medical education and is a Certified Compliance and Ethics Professional (CCEP) and has his Healthcare Meeting Compliance Certificate (HMCC).
Pat Schaumann
Pat is a Strategic Consultant with Maritz Global Events.
Pat is the author of “Breaking the Code to Healthcare Compliance”, 5th Edition, a health policy resource book for meeting professionals, physicians and manufacturers that addresses the impact of the National Physician Payment Transparency Program: Open Payments (formally the Physician Payments Sunshine Act) and global cross-border compliance. The book is the resource for the Healthcare Meeting Compliance Certificate program being offered globally through MPI, St. Louis University and the Convention Industry Council CMP-HC certification program. She is also the Executive Editor of the newly released “MPI CMP Healthcare Training Manual” and “The Guide to Successful Destination Management”. Pat is a contributing editor to 5 editions of the CIC Manual.
The Healthcare Meeting Compliance Certificate (HMCC) program was designed by Pat and currently has 2,200 recipients representing 16 countries. Pat was recently named by Meetings Today as on the 2016 Meetings Trendsetters and was again named One of the Top 25 Women in the Meetings Industry. She was recently recognized, for the fifth time, by Successful Meetings magazine as One of the 25 Most Influential People in the Meetings Industry. Her honors include being named the first recipient of the International Destination Management Professional of the Year by ADME International, named as One of the Magnificent 7 in the Global Hospitality Industry and was most recently named as One of the 25 Most Influential Women in Business by the St. Louis Business Journal. Pat was also selected as Meeting Professional of the Year by the MPI-St. Louis Chapter and Event Professional of the Year by the International Live Events Association.
She is proud of her impact and roots within the Hospitality Industry. She is past president of Meeting Professionals International (MPI), St. Louis Chapter, Founder and Past President of the International Live Events Association and Past President of the Association of Destination Management Executives International (ADME).
She has served as an adjunct Professor at 4 universities and currently Co-chairs the Hospitality Management Industry Advisory Board at St. Louis University’s School of Professional Studies and serves as manager and faculty for the Healthcare Meeting Compliance Certificate.
Steve McNelley PhD
View Instructor’s ProfileTaya Paige, CMM CIS HMCC
Taya Paige has over 25 years of meeting, incentive and recognition industry experience, including leadership positions in sales, marketing and operations and as an entrepreneur. Throughout these years, she has maintained a focus on the life sciences industry among other markets as well. She is a strategic thought leader and passionate about the pursuit of engagement. She is well-known for her ability to build a robust network of U.S. and global relationships driving innovation solutions, results and building deep and long-lasting partnerships that have made her a reliable and trustworthy resource.
Paige received her Bachelor’s degree in Hospitality and Business from Ithaca College in New York and has earned the Certified Meetings Professional (CMP), Certificate in Meeting Management (CMM), an MBA-level executive education for meeting professionals and is a faculty member of the Healthcare Meeting Compliance Certificate (HMCC) program. She has served on the MPI-MD Advisory Board since its inception and is the Director of the Thought Leadership & Advocacy Counsel. She also led the initiative for ITA Group to earn the Ethical MedTech Europe Trusted Partner certification.